SCHEMBL23930830

SCHEMBL23930830

COC(=O)c1c(Cl)ncn1C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.49
GPR119 Q8TDV5 4/20 0.45
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
CTSD P07339 1/20 0.43
CTSE P14091 1/20 0.43
BACE1 P56817 1/20 0.43
NR3C1 P04150 3/20 0.43
STS P08842 3/20 0.43
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
THRB P10828 1/20 0.42
NPC1 O15118 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
EED O75530 1/20 0.42
RBBP4 Q09028 1/20 0.42
SUZ12 Q15022 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24126466 0.93 SRC (0.44) HCAR1GPR119ALDH1A1POLBCTSD
SCHEMBL23960115 0.93 SRC (0.44) HCAR1GPR119ALDH1A1POLBCTSD
SCHEMBL21879883 0.88 POLB (0.40) HCAR1GPR119POLB
SCHEMBL21880090 0.88 ALDH1A1 (0.48) HCAR1GPR119ALDH1A1POLBMAPT
SCHEMBL21879888 0.82 SRC (0.48) HCAR1GPR119POLB
SCHEMBL21879911 0.82 SRC (0.48) HCAR1GPR119POLB
SCHEMBL21879885 0.82 SRC (0.48) HCAR1GPR119POLB
SCHEMBL23930836 0.79 GPR119 (0.35) HCAR1GPR119ALDH1A1POLBSTS
SCHEMBL10137696 0.76 CCNA2 (0.50) HCAR1GPR119POLBNR3C1
SCHEMBL948610 0.76 HCAR1 (0.54) HCAR1GPR119CTSDCTSEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed